301 related articles for article (PubMed ID: 36838987)
21. Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
Li LX; Zhou JX; Calvet JP; Godwin AK; Jensen RA; Li X
Cell Death Dis; 2018 Feb; 9(3):326. PubMed ID: 29487338
[TBL] [Abstract][Full Text] [Related]
22. Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species.
Calpena E; Palau F; Espinós C; Galindo MI
PLoS One; 2015; 10(7):e0134106. PubMed ID: 26230726
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional profiling of the human histone methyltransferase SMYD3.
Foreman KW; Brown M; Park F; Emtage S; Harriss J; Das C; Zhu L; Crew A; Arnold L; Shaaban S; Tucker P
PLoS One; 2011; 6(7):e22290. PubMed ID: 21779408
[TBL] [Abstract][Full Text] [Related]
24. Unique SMYD5 Structure Revealed by AlphaFold Correlates with Its Functional Divergence.
Zhang Y; Alshammari E; Sobota J; Yang A; Li C; Yang Z
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740908
[TBL] [Abstract][Full Text] [Related]
25. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription.
Yang Z; Liu F; Li Z; Liu N; Yao X; Zhou Y; Zhang L; Jiang P; Liu H; Kong L; Lang C; Xu X; Jia J; Nakajima T; Gu W; Zheng L; Zhang Z
Clin Epigenetics; 2023 May; 15(1):92. PubMed ID: 37237385
[TBL] [Abstract][Full Text] [Related]
26. Biochemical characterization of human SET and MYND domain-containing protein 2 methyltransferase.
Wu J; Cheung T; Grande C; Ferguson AD; Zhu X; Theriault K; Code E; Birr C; Keen N; Chen H
Biochemistry; 2011 Jul; 50(29):6488-97. PubMed ID: 21678921
[TBL] [Abstract][Full Text] [Related]
27. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia.
Oliveira-Santos W; Rabello DA; Lucena-Araujo AR; de Oliveira FM; Rego EM; Pittella Silva F; Saldanha-Araujo F
Tumour Biol; 2016 Jul; 37(7):9473-81. PubMed ID: 26790435
[TBL] [Abstract][Full Text] [Related]
28. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase.
Abu-Farha M; Lambert JP; Al-Madhoun AS; Elisma F; Skerjanc IS; Figeys D
Mol Cell Proteomics; 2008 Mar; 7(3):560-72. PubMed ID: 18065756
[TBL] [Abstract][Full Text] [Related]
29. Cardiac deletion of Smyd2 is dispensable for mouse heart development.
Diehl F; Brown MA; van Amerongen MJ; Novoyatleva T; Wietelmann A; Harriss J; Ferrazzi F; Böttger T; Harvey RP; Tucker PW; Engel FB
PLoS One; 2010 Mar; 5(3):e9748. PubMed ID: 20305823
[TBL] [Abstract][Full Text] [Related]
30. Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Zhang Y; Yan L; Yao W; Chen K; Xu H; Ye Z
Med Sci Monit; 2019 Jan; 25():193-239. PubMed ID: 30616239
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.
Friedman J; Cho WK; Chu CK; Keedy KS; Archin NM; Margolis DM; Karn J
J Virol; 2011 Sep; 85(17):9078-89. PubMed ID: 21715480
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex.
Brown MA; Sims RJ; Gottlieb PD; Tucker PW
Mol Cancer; 2006 Jun; 5():26. PubMed ID: 16805913
[TBL] [Abstract][Full Text] [Related]
33. The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network.
Codato R; Perichon M; Divol A; Fung E; Sotiropoulos A; Bigot A; Weitzman JB; Medjkane S
Sci Rep; 2019 Nov; 9(1):17298. PubMed ID: 31754141
[TBL] [Abstract][Full Text] [Related]
34. Structural and biochemical studies of human lysine methyltransferase Smyd3 reveal the important functional roles of its post-SET and TPR domains and the regulation of its activity by DNA binding.
Xu S; Wu J; Sun B; Zhong C; Ding J
Nucleic Acids Res; 2011 May; 39(10):4438-49. PubMed ID: 21266482
[TBL] [Abstract][Full Text] [Related]
35. Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart.
Warren JS; Tracy CM; Miller MR; Makaju A; Szulik MW; Oka SI; Yuzyuk TN; Cox JE; Kumar A; Lozier BK; Wang L; Llana JG; Sabry AD; Cawley KM; Barton DW; Han YH; Boudina S; Fiehn O; Tucker HO; Zaitsev AV; Franklin S
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7871-E7880. PubMed ID: 30061404
[TBL] [Abstract][Full Text] [Related]
36. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
[TBL] [Abstract][Full Text] [Related]
37. smyd1 and smyd2 are expressed in muscle tissue in Xenopus laevis.
Kawamura S; Yoshigai E; Kuhara S; Tashiro K
Cytotechnology; 2008 Jun; 57(2):161-8. PubMed ID: 19003161
[TBL] [Abstract][Full Text] [Related]
38. Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.
Colón-Bolea P; Crespo P
Bioessays; 2014 Dec; 36(12):1162-9. PubMed ID: 25382779
[TBL] [Abstract][Full Text] [Related]
39. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
[TBL] [Abstract][Full Text] [Related]
40. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease.
Bhat KP; Ümit Kaniskan H; Jin J; Gozani O
Nat Rev Drug Discov; 2021 Apr; 20(4):265-286. PubMed ID: 33469207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
